Zobrazeno 1 - 10
of 48
pro vyhledávání: '"N Madranges"'
Autor:
Marie-Ange Mouret-Reynier, Véronique D'Hondt, Audrey Mailliez, Gaëtane Simon, Damien Parent, Silvia Ilie, N. Madranges, Christelle Levy, David Pérol, Gaëlle Chenuc, Pierre Heudel, Thomas Vermeulin, Lionel Uwer, Paule Augereau, Thierry Petit, Suzette Delaloge, Florence Dalenc, Christophe Perrin, Etienne Brain, Jean-Sebastien Frenel, Anthony Gonçalves, Jean-Christophe Eymard, Jean-Marc Ferrero, Mathieu Robain, Marie-Paule Sablin
Publikováno v:
Anticancer Research
Anticancer Research, International Institute of Anticancer Research, 2020, 40 (7), pp.3905-3913. ⟨10.21873/anticanres.14381⟩
Anticancer Research, International Institute of Anticancer Research, 2020, 40 (7), pp.3905-3913. ⟨10.21873/anticanres.14381⟩
Background/aim Vinorelbine is indicated for use in the treatment of MBC as a single agent or in combination but there is little real world data on this molecule and even less on its oral form. We exploited the Unicancer Epidemiology Strategy Medical-
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::617a1f7090bc6531688599f52d2e7eb4
https://hal.archives-ouvertes.fr/hal-02995541
https://hal.archives-ouvertes.fr/hal-02995541
Autor:
Thierry Petit, Brigitte De La Lande, Jean-Marc Ferrero, Audrey Mailliez, Amélie Lusque, Clémentine Jankowski, Nelly Firmin, Florence Dalenc, Elvire Pons-Tostivint, Lionel Uwer, David Pasquier, Marie-Ange Mouret-Reynier, Delphine Mouttet-Boizat, Thomas Filleron, N. Madranges, Anthony Gonçalves, Julien Geffrelot, Youlia M. Kirova, Mario Campone, Agathe Crouzet, Mathieu Robain, Sofia Rivera, Jean-Christophe Eymard, Thibault De La Motte Rouge, C. Courtinard, Nicolas Pouget
Publikováno v:
Radiotherapy and Oncology
Radiotherapy and Oncology, Elsevier, 2020, 145, pp.109-116. ⟨10.1016/j.radonc.2019.12.019⟩
Radiotherapy & Oncology
Radiotherapy & Oncology, 2020, 145, pp.109-116. ⟨10.1016/j.radonc.2019.12.019⟩
Radiotherapy and Oncology, Elsevier, 2020, 145, pp.109-116. ⟨10.1016/j.radonc.2019.12.019⟩
Radiotherapy & Oncology
Radiotherapy & Oncology, 2020, 145, pp.109-116. ⟨10.1016/j.radonc.2019.12.019⟩
The impact of locoregional treatment (LRT) on overall survival (OS) in de novo metastatic breast cancer (dnMBC) is still under debate, with very few data available regarding exclusive radiotherapy (ERT) as a therapeutic modality.We evaluated the impa
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b0251e82da3d7175fa536f89de39453d
https://hal.archives-ouvertes.fr/hal-02888440
https://hal.archives-ouvertes.fr/hal-02888440
Autor:
Xavier Pivot, Gilles Romieu, Marc Debled, Jean-Yves Pierga, Pierre Kerbrat, Thomas Bachelot, Alain Lortholary, Marc Espié, Pierre Fumoleau, Daniel Serin, Jean-Philippe Jacquin, Christelle Jouannaud, Maria Rios, Sophie Abadie-Lacourtoisie, Laurence Venat-Bouvet, Laurent Cany, Stéphanie Catala, David Khayat, Laetitia Gambotti, Iris Pauporté, Celine Faure-Mercier, Sophie Paget-Bailly, Julie Henriques, Jean Marie Grouin, C Piprot, L Cals, L Chaigneau, F Demarchi, T N'Guyen, U Stein, C Villanueva, JL Bréau, AK Chouahnia, P Saintigny, F Boué, P deSaint-Hilaire, I Guimont, N Grossat, B Valenza, E Lévy, J Médioni, C Delbaldo, J Grenier, D Pouessel, S Lavau-Denès, C Falandry, C Fournel-Fédérico, G Freyer, S Tartas, V Trillet-Lenoir, F Bons, G Auclerc, S Chièze, N Raban, C Tournigand, S Trager-Maury, G Bousquet, C Cuvier, S Giacchetti, A Hocini, C LeMaignan, JL Misset, D Avenin, C Beerblock, J Gligorov, P Rivera, H Roché, P Bougnoux, N Hajjaji, O Capitain, R Delva, P Maillart, P Soulié, H Bonnefoi, M Durand, N Madranges, L Mauriac, P Chollet, AF Dillies, X Durando, JP Ferrière, C Mouret-Reynier, JM Nabholtz, I Van Praagh, P Cottu, V Diéras, A Durieux, M Galotte, V Girre, S Henry, I Iurisci, M Jouve, V Laurence, L Mignot, S Piperno-Neumann, P Tresca, B Coudert, E Ferrant, F Mayer, AC Vanneuville, J Bonneterre, V Servent, L Vanlemmens, P Vennin, JP Guastalla, P Biron, L Dupuy-Brousseau, L Lancry, I Ray-Coquard, P Rebattu, O Trédan, JM Extra, F Rousseau, C Tarpin, M Fabbro, E Luporsi, L Uwer, B Weber, D Berton-Rigaud, E Bourbouloux, M Campone, JM Ferrero, P Follana, R Largillier, V Mari, B Costa, H Curé, JC Eymard, N Jovenin, D Lebrun, J Meunier, G Yazbek, D Gedoin, B Laguerre, C Lefeuvre, E Vauléon, A Chevrier, C Guillemet, M Leheurteur, O Rigal, I Tennevet, C Veyret, E Brain, M Guiterrez, F Mefti-Lacheraf, T Petit, F Dalenc, L Gladieff, F André, S Delaloge, J Domont, J Ezenfis, M Spielmann, P Guillet, V Boulanger, J Provençal, L Stefani, C Alliot, D Ré, C Bellaiche-Miccio, G Boutan-Laroze, R Vanica, P Dion, G Sadki-Benaoudia, A Marti, AL Villing, B Slama, JL Dutel, S Nguyen, R Saad, O Arsène, Z Merad-Boudia, H Orfeuvre, J Egreteau, MJ Goudier, R Lamy, B Leduc, C Sarda, B Salles, C Agostini, I Cauvin, A Dufresne, M Mangold, S Lebouvier-Sadot, B Audhuy, JC Barats, S Cluet-Dennetière, D Zylberait, G Netter, L Gautier-Felizot, I Cojean-Zelek, A Plantade, S Vignot, E Guardiola, P Marti, I deHartingh, R Diab, A Dietmann, S Ruck, C Portois, S Oddou-Lagranière, F Campos-Gazeau, A Bourcier, F Priou, JF Geay, D Mayeur, P Gabez, R ElAmarti, M Combe, P Raichon-Patru, P Amsalhem, J Dauba, D Paraiso, F Guinet, B Duvert, M Litor, F Kara-Slimane, A Bichoffe, N Denizon, P Soyer, F Morvan, S Van-Hulst, L Vincent, C Alleaume, P Ibanez-Martin, A Youssef, Z Tadrist, E Carola, C Pourny, JF Toccanier, N Al-Aukla, K Mahour-Bacha, J Salvat, P Nouyrigat, S Clippe, MC Gouttebel, L Vedrine, G Clavreul, O Collard, D Mille, Y Goubely, R Hervé, S Kirscher, F Plat, V Delecroix, V Ligeza-Poisson, D Coeffic, D Fric, C Garnier, C Leyronnas, T Kreitman, E Teissier, P Martin, S Rohart deCordoue, C ElKouri, JF Ramée, C Laporte, O Bernard, T Altwegg, A Darut-Jouve, JP Dujols, F Darloy, C Giraud, V Pottier-Kyndt, N Achour, S Drony, M Moriceau, C Sarrazin, JC Legueul, J Mandet, D Besson, AC Hardy-Bessard, J Cretin, P Houyau, E Achille, D Genêt, H Thévenot, A Moran-Ribon, JM Pavlovitch, P Ardisson, I Moullet, B Couderc, V Fichet, F Burki, A Auliard, CB Levaché, P Cailleux, F Schaeffer, N Albin, D Sévin-Robiche, J Domas, S Ellis, P Montcuquet, GA Baumont, M Bégue, S Gréget, JL Ratoanina, A Vanoli, C Bielsa, M Bonichon-Lamichhane, D Jaubert, H Laharie-Mineur, L Alcaraz, E Legouffe, H Bourgeois, G Cartron, F Denis, O Dupuis, G Ganem, S Roche-Forestier, L Delzenne, E Chirat, JL Baticle, E Béguier, S Jacquot, E Janssen, H Lauché, A LeRol, JP Chantelard, GA L'Helgoualc'h, EC Antoine, A Kanoui, JF Llory, JM Vannetzel, J Vignoud, C Bruna, T Facchini, K Moutel-Corviole, A Voloch, A Ghoul, D Loiseau, N Barbet, N Dohollou, K Yakendji
Publikováno v:
Lancet (London, England). 393(10191)
Summary Background In 2013, the interim analysis of the Protocol for Herceptin as Adjuvant therapy with Reduced Exposure (PHARE) trial could not show that 6 months of adjuvant trastuzumab was non-inferior to 12 months. Here, we report the planned fin
Autor:
Marc Debled, Hayssam Soueidan, L. Mauriac, Thomas Bachelot, Justine Rudewicz, Barbara Lortal, Pamela Rabbitts, Hervé Bonnefoi, Richard Iggo, Catherine Daly, Gaëtan MacGrogan, Henry M. Wood, N. Madranges, C. Breton-Callu, Christine Tunon de Lara, Macha Nikolski, N Quenel-Tueux, Audrey Gros, Marina Pulido, M. Fournier, Florence Dalenc
Publikováno v:
British Journal of Cancer
British Journal of Cancer, Cancer Research UK, 2015, pp.bjc.2015.247. ⟨10.1038/bjc.2015.247⟩
British Journal of Cancer, Cancer Research UK, 2015, pp.bjc.2015.247. ⟨10.1038/bjc.2015.247⟩
International audience; BACKGROUND:The aim of this study was to assess the efficacy of neoadjuvant anastrozole and fulvestrant treatment of large operable or locally advanced hormone-receptor-positive breast cancer not eligible for initial breast-con
Autor:
Camille Chakiba, Laurent Mignot, Hervé Bonnefoi, N. Madranges, Paul Cottu, Dorothee Chocteau-Bouju, Jean-Yves Pierga, N Quenel-Tueux, Philippe Beuzeboc, Véronique Diéras, Marc Debled
Publikováno v:
Cancer Research. 75:P5-19
Background: The on line publication in December 2011 of the Bolero-2 study (Baselga et al, NEJM) establishing the added value of everolimus (Eve) in endocrine resistant breast cancer (BC) patients (pts) has triggered its immediate use in current prac
Autor:
L. Mauriac, P Campo, C. Tunon de Lara, Florence Dalenc, Marc Debled, Thomas Bachelot, Hervé Bonnefoi, N Quenel-Tueux, N. Madranges, Marina Pulido, Richard Iggo, Barbara Lortal
Publikováno v:
Cancer Research. 73:P1-15
Background: Neoadjuvant endocrine therapy improves surgical outcomes for postmenopausal women with hormone-receptor-positive (HR+) breast cancer. We performed a prospective trial aiming to assess the response rate of an aromatase inhibitor (anastrozo
Autor:
M. Asad-Syed, Catherine Payet, N. Madranges, Nathalie Malingret, Marc Debled, Marie-Hélène Dilhuydy, Louis-Marie Écomard
Publikováno v:
Bulletin du Cancer. 100:671-678
Breast cancer among older women is a major and increasing public health issue. No clear recommendation has been established in France after 74 years, the age limit for state-organised screening program. A survey was performed among all regional agenc
Autor:
Olivier Tredan, Charlotte Proudhon, C. Orsini, N. Madranges, A. Mailliez, Anthony Gonçalves, I. Desmoulins, J. Grenier, Sophie Abadie-Lacourtoisie, Paul Cottu, T Grellety, Jérôme Dauba, M. Mousseau, François-Clément Bidard, Florence Dalenc, F. Del Piano, Benoit You, Florence Coussy, Mahasti Saghatchian, Marina Pulido, Tifenn Lharidon, Gaëtan MacGrogan, Hervé Bonnefoi
Publikováno v:
Annals of Oncology
Annals of Oncology, Elsevier, 2016, 27 (5), pp.812-818. ⟨10.1093/annonc/mdw067⟩
Annals of Oncology, Elsevier, 2016, 27 (5), pp.812-818. ⟨10.1093/annonc/mdw067⟩
International audience; BACKGROUND: Several expression array studies identified molecular apocrine breast cancer (BC) as a subtype that expresses androgen receptor (AR) but not estrogen receptor alpha. We carried out a multicentre single-arm phase II
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3cdb5208f5bc699ad967c742a5e33d01
https://hal.archives-ouvertes.fr/hal-01791274
https://hal.archives-ouvertes.fr/hal-01791274
Autor:
Hervé Bonnefoi, N Quenel-Tueux, Philippe Beuzeboc, C. Chakiba, N. Madranges, Marc Debled, Paul-Henri Cottu, L. Mignot, J-Y Pierga, Véronique Diéras, Dorothee Chocteau-Bouju
Publikováno v:
Breast (Edinburgh, Scotland). 24(6)
Background Since the publication of the Bolero-2 trial, everolimus has entered the routine care for advanced endocrine resistant luminal breast cancer (BC). We evaluated our practice 2 years after the French marketing authorization (July 2012). Metho
Autor:
Florence Mercier, Paul Cottu, Christelle Levy, François Emery Cotté, Daniel Serin, Bruno Coudert, Sabine Laulhere-Vigneau, C. Simondi, Thomas Bachelot, Dominique Spaeth, Cristian Moldovan, Cathie Maillard, Maya Gutierrez, N. Madranges, Emilie Le Rhun, L Benjamin, Youlia M. Kirova, Isabelle Durand-Zaleski, Sandrine Baffert
Publikováno v:
BMC Health Services Research
Background The population of patients with human epidermal growth factor receptor 2 (HER2)-positive breast cancer (BC) who develop central nervous system (CNS) metastases is growing. Treatment strategies in this population are highly diverse. The obj